Investors who lost money with shares of Pacira BioSciences, Inc. (NASDAQ: PCRX) should contact the Shareholders Foundation in connection with Lawsuit
Investors who purchased shares of Pacira BioSciences, Inc. prior to August 2023 and continue to hold any of those NASDAQ: PCRX shares also have certain options and contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
On January 13, 2025, an investor in NASDAQ: PCRX shares filed a lawsuit over alleged violations of securities laws by Pacira BioSciences, Inc. The plaintiff alleged that the defendants made false and/or misleading statements and/or failed to disclose that defendants created the false impression that Pacira had sufficient patent protections on Exparel, and as such, the ability to expand the marketing, production, and sales of Exparel, which Pacira stated was critical to its future growth and revenue, that Pacira knew that the '495 patent was not as protective as Pacira publicly touted because on June 6, 2023, the United States District Court for the District of New Jersey issued a ruling in eVenus Pharmaceutical Laboratories, Inc.'s favor regarding claims construction in another case filed by Pacira in a failed attempt to protect Exparel, and that therefore, when the '495 patent was invalidated in another case Pacira filed against eVenus, investors and analysts alike were shocked by the concerning news that Exparel, which accounts for approximately 80% of Pacira's revenue, did not have sufficient patent protection to prevent another company from producing a generic during the life of the patent.
Those who purchased NASDAQ: PCRX shares should contact the Shareholders Foundation, Inc.
CONTACT:
Shareholders Foundation, Inc. Michael Daniels +1 (858) 779-1554 mail@shareholdersfoundation.com 3111 Camino Del Rio North Suite 423 San Diego, CA 92108
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BusinessToday
2 days ago
- BusinessToday
Dow Hits Record High, Mixed Data Pressures Broader Market
Pic source: FX Empire The Dow Jones Industrial Average ended modestly higher on Aug 15 after touching a fresh intraday record, lifted by a sharp rally in UnitedHealth Group's shares, even as the S&P 500 and Nasdaq fell on mixed economic signals that clouded the Federal Reserve's (Fed) next policy move. Reuters reported that UnitedHealth jumped nearly 12%, its biggest one-day gain since March 2020, after Berkshire Hathaway disclosed a new stake in the health insurer, while Scion Asset Management also boosted its holdings. The surge helped the healthcare sector log its best weekly performance since October 2022. The Dow gained 34.86 points, or 0.08%, to close at 44,946.12. The S&P 500 slipped 0.29% to 6,449.80 and the Nasdaq Composite fell 0.40% to 21,622.98. For the week, the Dow rose 1.74%, the S&P 500 added 0.94% and the Nasdaq advanced 0.81%. The small-cap Russell 2000 outperformed with a 3.13% weekly gain. Markets remain focused on the Fed, with traders betting on a 25-basis-point rate cut in September following signs of labour market weakness and muted tariff-driven inflation. However, Chicago Fed President Austan Goolsbee urged caution, noting uneven economic data. July retail sales grew in line with forecasts, but factory output and consumer sentiment weakened under tariff pressures. Geopolitical developments also loomed large. Investors eyed a meeting between US President Donald Trump and Russian President Vladimir Putin in Alaska, seen as pivotal for Ukraine peace prospects and the outlook for crude oil prices. Trump also signalled new tariffs on steel and semiconductors could be unveiled next week. Trading volumes were lighter than average, with 16.3 billion shares changing hands across US exchanges versus a 20-session average of 18.2 billion.
The Star
2 days ago
- The Star
Dow ends higher, other indices slip on rate-cut uncertainty
The Dow rose 34.86 points, or 0.08%, to 44,946.12, the S&P 500 lost 18.74 points, or 0.29%, to 6,449.80 and the Nasdaq lost 87.69 points, or 0.40%, to 21,622.98. NEW YORK: The blue-chip Dow Jones ended higher after hitting an intraday record high on Friday, as UnitedHealth's shares jumped after Berkshire Hathaway raised its stake, but other Wall Street indices slipped as mixed data clouded the Federal Reserve's next monetary policy move. A meeting between US President Donald Trump and Russian counterpart Vladimir Putin was also on the radar, with markets hoping it could pave the way for a resolution to the Ukraine conflict and determine the outlook for crude prices. The two leaders began a meeting in Alaska on Friday afternoon.
Malaysian Reserve
2 days ago
- Malaysian Reserve
Travelzoo Receives Highest Rating for Consumer Satisfaction from FOCUS MONEY Magazine in Germany
BERLIN, Aug. 15, 2025 /PRNewswire/ — Travelzoo® (NASDAQ: TZOO), the club for travel enthusiasts, has received the highest possible ranking for consumer satisfaction from FOCUS MONEY, one of the most popular print magazines in Germany. Consumers were asked to rate 632 digital brands across 62 categories. More than 94,000 FOCUS MONEY readers participated in the survey, conducted in partnership with market research institute ServiceValue. Travelzoo received the highest ranking for travel deals, 'Bestnote'. This recognition of excellence was awarded just a few weeks after Travelzoo was ranked number 1 in another national survey, commissioned by BILD Zeitung, Germany's largest newspaper. 'We are very happy to see that consumers trust and love Travelzoo,' said Christian Smart, Travelzoo's General Manager, Germany. 'Our team works passionately to find and curate the very best travel deals for Cub Members.' Are you a travel enthusiast? Join the club today: About TravelzooWe, Travelzoo®, are the club for travel enthusiasts. We reach 30 million travelers. Club Members receive Club Offers personally reviewed by our deal experts around the globe. We have our finger on the pulse of outstanding travel, entertainment, and lifestyle experiences. We work in partnership with thousands of top travel suppliers—our long-standing relationships give us access to irresistible deals. Travelzoo is a registered trademark of Travelzoo. All other names are trademarks and/or registered trademarks of their respective owners. Media Contact: Mara Zatti – Berlin+49 30 3119 7514mzatti@
